1-8 of 8
Bin Shi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 2888: Lipid nanoparticle-mediated delivery of siRNA to extrahepatic tumors

Joseph P. Davide, Bruce Ng, Xianzhi Mao, Manishkumar Patel, Bin Shi, Jerome Hochman, James J. Cunningham, Laura Sepp-Lorenzino, Weikang Tao
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 2888.
https://doi.org/10.1158/1538-7445.AM2012-2888
Published: 15 April 2012
View article titled, Abstract 2888: Lipid nanoparticle-mediated delivery of siRNA to extrahepatic tumors
Journal Articles

Molecular Mechanisms Involved in the Growth Stimulation of Breast Cancer Cells by Leptin

Na Yin, Dan Wang, Hua Zhang, Xia Yi, Xiaojing Sun, Bin Shi, Huijian Wu, Ge Wu, Xinjuan Wang, Yongfeng Shang
Journal: Cancer Research
Cancer Res (2004) 64 (16): 5870–5875.
https://doi.org/10.1158/0008-5472.CAN-04-0655
Published: 16 August 2004
View article titled, Molecular Mechanisms Involved in the Growth Stimulation of Breast Cancer Cells by Leptin
Open the PDF for Molecular Mechanisms Involved in the Growth Stimulation of Breast Cancer Cells by Leptin in another window
Journal Articles

Identification of gene expression biomarkers to assess tumor endothelial cell proliferation.

James S. Hardwick, Yi Yang, Chunsheng Zhang, Bin Shi, Rosemary C. McFall, Elizabeth J. Koury, Susan L. Hill, Hongyue Dai, Robert Wasserman, Robert L. Phillips, Edward J. Weinstein, Nancy E. Kohl, Michael E. Severino, John R. Lamb, Laura Sepp-Lorenzino
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 751.
Published: 01 April 2004
View article titled, Identification of gene expression biomarkers to assess tumor endothelial cell proliferation.
Journal Articles

Anti-tumor and anti-metastatic effects of novel oral bioavailable KDR inhibitors in rat tumor models

Bin Shi, Susan Hill, Laura Schina, Rosemary McFall, Xianzhi Mao, Noelle P. Dahl, Cindy Spencer Bauer, Sandra Veggian, Ryan Desautels, Brad Smith, Jeannine Manzella, Jim Destefano, Totoe Kuffuor, Alan Savitz, Patricia Rebbeck, Lenora Davis, Jennifer Shipman, Yi Yang, James Hardwick, Seth Clark, Varaporn Treemaneekarn, Kenneth Thomas, Jackson Gibbs, Nancy Kohl, Laura Sepp-Lorenzino
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 1053.
Published: 01 April 2004
View article titled, Anti-tumor and anti-metastatic effects of novel oral bioavailable KDR inhibitors in rat tumor models
Journal Articles

Novel Flt-3/KDR inhibitor is effective against activated Flt-3 and is cytotoxic against Flt-3-driven leukemias in vitro and in vivo

Stephen Beck, Lenora Davis, Jennifer Shipman, Laura Schina, Bin Shi, Kathleen Coll, Keith Rickert, Anne Johnson, Qinwen Zeng, Bo-Sheng Pan, Kenneth Thomas, Aimee Dallob, Mary Flynn, Wesley Tanaka, Maricel Torrent, Yih Lee, Kathryn Mazina, Sarah Liou, Dale Schaar, Malgorzata Wojtowicz, Paul Deutsch, Marian Iwamoto, Jackson Gibbs, Nancy Kohl, Laura Sepp-Lorenzino
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 1301.
Published: 01 April 2004
View article titled, Novel Flt-3/KDR inhibitor is effective against activated Flt-3 and is cytotoxic against Flt-3-driven leukemias <em>in vitro</em> and <em>in vivo</em>
Journal Articles

Derivation and Initial Characterization of a Mouse Mammary Tumor Cell Line Carrying the Polyomavirus Middle T Antigen: Utility in the Development of Novel Cancer Therapeutics

Loretta L. Nielsen, Maya Gurnani, Bin Shi, Gaby Terracina, Robert C. Johnson, Jennifer Carroll, J. Michael Mathis, Gerald Hajian
Journal: Cancer Research
Cancer Res (2000) 60 (24): 7066–7074.
Published: 01 December 2000
View article titled, Derivation and Initial Characterization of a Mouse Mammary Tumor Cell Line Carrying the Polyomavirus Middle T Antigen: Utility in the Development of Novel Cancer Therapeutics
Open the PDF for Derivation and Initial Characterization of a Mouse Mammary Tumor Cell Line Carrying the Polyomavirus Middle T Antigen: Utility in the Development of Novel Cancer Therapeutics in another window
Journal Articles

Antiangiogenic Scheduling of Chemotherapy Improves Efficacy against Experimental Drug-resistant Cancer

Timothy Browder, Catherine E. Butterfield, Birgit M. Kräling, Bin Shi, Blair Marshall, Michael S. O’Reilly, Judah Folkman
Journal: Cancer Research
Cancer Res (2000) 60 (7): 1878–1886.
Published: 01 April 2000
View article titled, Antiangiogenic Scheduling of Chemotherapy Improves Efficacy against Experimental Drug-resistant Cancer
Open the PDF for Antiangiogenic Scheduling of Chemotherapy Improves Efficacy against Experimental Drug-resistant Cancer in another window
Journal Articles

Combination Therapy with the Farnesyl Protein Transferase Inhibitor SCH66336 and SCH58500 (p53 Adenovirus) in Preclinical Cancer Models

Loretta L. Nielsen, Bin Shi, Gerald Hajian, Bohden Yaremko, Philip Lipari, Eric Ferrari, Maya Gurnani, Michael Malkowski, Jiaping Chen, W. Robert Bishop, Ming Liu
Journal: Cancer Research
Cancer Res (1999) 59 (23): 5896–5901.
Published: 01 December 1999
View article titled, Combination Therapy with the Farnesyl Protein Transferase Inhibitor SCH66336 and SCH58500 (p53 Adenovirus) in Preclinical Cancer Models
Open the PDF for Combination Therapy with the Farnesyl Protein Transferase Inhibitor SCH66336 and SCH58500 (p53 Adenovirus) in Preclinical Cancer Models in another window